Login / Signup

Decitabine-Containing Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Intermediate- and High-Risk Myelodysplastic Syndrome/Acute Myeloid Leukemia: Potential Decrease in the Incidence of Acute Graft versus Host Disease.

Qing Ya WangYuan LiZe Yin LiangYue YinWei LiuQian WangYu Jun DongYu Hua SunWei Lin XuHan Yun Ren
Published in: Cancer management and research (2019)
Inclusion of Decitabine in the conditioning regimen for allo-HSCT in intermediate- and high-risk patients may lower the incidence of aGVHD and respiratory infections, and contribute to longer median relapse time.
Keyphrases